4 Results for "

CREKA-YpFFK(Nph)

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CREKA-YpFFK(Nph)" in MCE Product Catalog:

Cat. No.: HY-P11054
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

CREKA-YpFFK(Nph) is a gold nanoparticle surface ligand composed of CREKA and YPFFK (Nph), responsible for tumor targeting and alkaline phosphatase-responsive bond cleavage, respectively. CREKA-YpFFK(Nph) can be used for tumor targeting research .
loading...
    loading...
Cat. No.: HY-P10709
CAS No.: 847058-45-1
Target:  

Collagen

Research Areas:  

Cardiovascular Disease Cancer

CREKA peptide is a selective non-covalent binding agent targeting fibrin, type IV collagen, and fibronectin, often used as a targeting ligand to modify delivery carriers. CREKA peptide specifically recognizes fibrin, fibronectin, and type IV collagen that are excessively deposited in the tumor microenvironment or fibrotic tissue, mediating the targeted accumulation of the carrier at the lesion site and promoting drug internalization into target cells (such as cancer cells and activated hepatic stellate cells). CREKA peptide can enhance targeted delivery efficiency, increase drug concentration at the lesion site, and reduce systemic side effects .
loading...
    loading...
Cat. No.: HY-P10709A
Research Areas:  

Cardiovascular Disease Cancer

CREKA peptide acetate is a short peptide sequence, belonging to self-assembling peptides (SAPs), which can self-assemble into functional nanostructures, typically nanofibers, under physiological conditions. CREKA peptide acetate can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity .
loading...
    loading...
Cat. No.: HY-P0186
CAS No.: 141801-26-5
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

Endomorphin 2, a high affinity, highly selective agonist of the μ-opioid receptor, displays reasonable affinities for kappa3 binding sites, with Ki value between 20 and 30 nM.
loading...
    loading...